[Adherence to treatment of hematological malignancies patients with anxiety and depression].

D E Vybornykh T N Moiseeva E G Gemdzhian Tatiana V Gaponova L V Esina E I Kolgaeva D V Novikova

Published in: Terapevticheskii arkhiv (2023)

Anxiety/depressive disorders contribute to reduced adherence of hematologic malignancies patients to treatment. Their correction and increased adherence should be carried out jointly by hematologists and mental health professionals.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
mental health
peritoneal dialysis
prognostic factors
metabolic syndrome
depressive symptoms